We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Avacta | LSE:AVCT | London | Ordinary Share | GB00BYYW9G87 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 43.25 | 43.00 | 43.50 | 43.25 | 43.25 | 43.25 | 54,877 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 23.25M | -24.95M | -0.0695 | -6.22 | 155.29M |
Date | Subject | Author | Discuss |
---|---|---|---|
04/11/2024 08:59 | Only if friendly. BP doesn't do hostile. | divmad | |
03/11/2024 22:40 | Bid approach could come any time. Likely no warning, first we'd know is RNS giving details with shares suspended from market. | cheshire pete | |
03/11/2024 22:08 | From LSE, pleasant change from the FUDsters here, bless them. Still here 1347 and Ama lol. | cheshire pete | |
03/11/2024 20:39 | Just confirms that all their previous pipeline has fallen by the wayside, just like their Covid19 tests and pretty much everything else they ever did. Rinse and repeat, enjoy the PowerPoints, they're costing a fortune. | 1347 | |
01/11/2024 11:32 | Sharing the video might just help! | pareden | |
01/11/2024 11:23 | Starting to pick up after the science presentation from earlier this week | robers98 | |
31/10/2024 18:05 | Pretty darn depressing price action. Woeful. Mkt fallen out of love here, no real ii support. Eons to get any product to mkt. Convis a perpetual thorn, even the blind now see it. Our great leader ,the Time Lord,Agent Smith, left to take residence at Gallifrei. Stone cold - no idea. Gravity back in the game now.Funding round anyone? Last couple of days at Budle Bay/ Ross. Gutted. Weather been superb. Happy days. Onwards and upwards, or wherever! | amanitaangelicus | |
31/10/2024 10:28 | stretched balance sheet suggests excellent short. | wiseacre | |
30/10/2024 21:35 | hxxps://x.com/jivetu | timmy11 | |
30/10/2024 11:02 | Sorry, can't seem to find that. Might be wrong, but suggests it's not live. A recording will be made available later. | tratante | |
30/10/2024 10:36 | What time is presentation TIA | carlsberg | |
30/10/2024 10:22 | 'Avacta's AVA6000, AVA6103, and AVA7100 programs are highly differentiated pipeline assets, addressing large markets. The presentation will also address these programs' near-term milestones.' | tratante | |
30/10/2024 08:50 | No indication that AVA6000 is progressing and confirmation that AVA3996 and all the others previously in the pipeline have been quietly dropped and they are left with just two pre-clinical pipeline candidates. As I’ve said, back to the drawing board. | 1347 | |
28/10/2024 15:37 | Sneaky 200/ being bought and more in the last 60 min | viking24 | |
25/10/2024 17:09 | Fraid wrong again ama. I don't trade anything on AIM let alone Avacta as I see as too risky. Happy to trade blue chips though as less chance of things going wrong. LTH of Avacta and happy with size of stake. Not advice to buy or sell, but plan to hold till taken over at which point likely to make a significant difference to value of portfolio. Money I can afford to lose if naysayers proven right but I'm not anticipating that. | cheshire pete | |
25/10/2024 12:07 | Not convinced AVA6k will be taken fwd. You trade eh Mr Cheshire. Shallow as. Geez. | amanitaangelicus | |
25/10/2024 06:25 | Nah, no favours, just reality. Still if you're all convinced by these 'ground breaking discoveries' then don't waste time here, just buy, buy, buy. In the meantime I'll base what I do on hard data and, after several years, all they have proven is that the Affimer LFT was, at the end of the day, a failure and that AVA6000 is safe with some observations as to possible efficacy and they've gone back to the drawing board with the 'next generation'. So that's the sum 'progress' since 2019. Still waiting to know when the Phase 1b trial starts, or won't it now? | 1347 | |
24/10/2024 20:18 | The berk here 1347, remember that's what you called me a while back. I refrained from saying what I think of you. Suffice to say I don't buy your negative posts or those of whitey, repins, or ama's 'even handedness'. I respect the honesty of Dudishes, as I also trade shares and have done well trading the banks recently. Have been able to do it though without posting stuff on bulletin boards. | cheshire pete | |
24/10/2024 17:53 | Big prints at EOD. | robers98 | |
24/10/2024 12:06 | Lomcovaks "I first bought in 2019 and have accumulated ever since. I understand it's super high risk but I don't need unthoughtful comments like yours that don't carry any weight when tested against reality." The reality is the Affimer tests failed, Phase 1 of AVA6000 thus far didn't get past Phase 1a and they have £30 m blance on the death spiral finance running, the share price tells it's own story. However if you want to believe in fairies, then be my guest. Oh and you can hit the filter button any time you like, it makes absolutely no difference whatsover to me, although I do agree with your point that it's super high risk. | 1347 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions